333 related articles for article (PubMed ID: 34876939)
1. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.
Halefoglu AM; Ozagari AA
Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939
[TBL] [Abstract][Full Text] [Related]
2. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
4. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
[TBL] [Abstract][Full Text] [Related]
5. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
6. [Role of multiphasic multidetector CT imaging in differential diagnosis of small renal cell carcinoma].
Zhang Y; Gao W; Zhao B; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):850-4. PubMed ID: 26887517
[TBL] [Abstract][Full Text] [Related]
7. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
[TBL] [Abstract][Full Text] [Related]
8. Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement.
Jung SC; Cho JY; Kim SH
Acta Radiol; 2012 Feb; 53(1):112-8. PubMed ID: 22114020
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.
Moldovanu CG; Petresc B; Lebovici A; Tamas-Szora A; Suciu M; Crisan N; Medan P; Buruian MM
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33126571
[No Abstract] [Full Text] [Related]
10. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
[TBL] [Abstract][Full Text] [Related]
11. Dynamic computed tomography and Doppler findings in different subtypes of renal cell carcinoma with their histopathological correlation.
Sureka B; Lal A; Khandelwal N; Joshi K; Singh SK; Agarwal MM; Mittal A
J Cancer Res Ther; 2014; 10(3):552-7. PubMed ID: 25313738
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
[TBL] [Abstract][Full Text] [Related]
13. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma.
Takahashi H; Vikram R; Jimenez RE; Bolan CW; Kawashima A; Karam JA; Takahashi N
Abdom Radiol (NY); 2021 Nov; 46(11):5250-5259. PubMed ID: 34338814
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
[TBL] [Abstract][Full Text] [Related]
16. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
18. Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT.
Toguchi M; Takagi T; Ogawa Y; Morita S; Yoshida K; Kondo T; Iizuka J; Ishida H; Nagashima Y; Tanabe K
Sci Rep; 2021 Jan; 11(1):2245. PubMed ID: 33500519
[TBL] [Abstract][Full Text] [Related]
19. Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.
Chen F; Huhdanpaa H; Desai B; Hwang D; Cen S; Sherrod A; Bernhard JC; Desai M; Gill I; Duddalwar V
Springerplus; 2015; 4():66. PubMed ID: 25694862
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of multiparametric magnetic resonance imaging in the differentiation of clear cell renal cell cancer.
Aydoğan C; Cansu A; Aydoğan Z; Erdemi S; Teymur A; Bektaş O; Mungan S; Kazaz İO
Abdom Radiol (NY); 2023 Jul; 48(7):2349-2360. PubMed ID: 37071122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
